Your browser doesn't support javascript.
loading
Synonymous ADAMTS13 variants impact molecular characteristics and contribute to variability in active protein abundance.
Jankowska, Katarzyna I; Meyer, Douglas; Holcomb, David D; Kames, Jacob; Hamasaki-Katagiri, Nobuko; Katneni, Upendra K; Hunt, Ryan C; Ibla, Juan C; Kimchi-Sarfaty, Chava.
Afiliação
  • Jankowska KI; OTAT/DPPT/HB in the Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD; and.
  • Meyer D; OTAT/DPPT/HB in the Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD; and.
  • Holcomb DD; OTAT/DPPT/HB in the Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD; and.
  • Kames J; OTAT/DPPT/HB in the Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD; and.
  • Hamasaki-Katagiri N; OTAT/DPPT/HB in the Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD; and.
  • Katneni UK; OTAT/DPPT/HB in the Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD; and.
  • Hunt RC; OTAT/DPPT/HB in the Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD; and.
  • Ibla JC; Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children's Hospital and Harvard Medical School, Boston, MA.
  • Kimchi-Sarfaty C; OTAT/DPPT/HB in the Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD; and.
Blood Adv ; 6(18): 5364-5378, 2022 09 27.
Article em En | MEDLINE | ID: mdl-35667091

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Trombótica / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Púrpura Trombocitopênica Trombótica / MicroRNAs Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Adv Ano de publicação: 2022 Tipo de documento: Article